THE use of detergents in the liquefaction of thick mucoid and purulent exudates in the alveoli and bronchial tree was not practical until recent years, owing to the fact that no surfactant with ...

The treatment uses a nanoparticle to mimic the behavior of a natural surfactant in the lungs to work within the lungs' processes for inflation and oxygenation. Disclaimer: AAAS and EurekAlert!

About aPAP Autoimmune PAP (aPAP) is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli (or air sacs) of the lungs. Surfactant consists of proteins and lipids ...

Objective: Recently, natural exogenous surfactant replacement has been used in experimental models and clinical trials for the treatment of severe respiratory syncytial virus (RSV) disease.